March 25, 2025
Headlines

Alvotech Strengthens Biosimilar Portfolio With $27 Million Xbrane R&D Deal

Sumain Faisal01 mins

Alvotech acquires Xbrane’s R&D operations and biosimilar candidate for SEK 275 million, enhancing development capabilities and expanding into Sweden.

read more

Join the newsletter

Subscribe to get our latest content by email.

    We respect your privacy. Unsubscribe at any time.
    Built with Kit

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    Related News